2,4-Dihydro-3H-1,2,4-triazole-3-thiones as Potential Antidepressant Agents

Journal of Medicinal Chemistry

Volumn 31, Issue 6, 1988, Pages 1253-1258

  Kane, John M ^a   Dudley, Mark W ^a   Sorensen, Stephen M ^a   Miller, Francis P ^a  

^a Merrell Dow Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 TRIAZOLE 3 THIONE DERIVATIVE; AMITRIPTYLINE; CLORGYLINE; DESIPRAMINE; IMIPRAMINE; NORADRENALIN; NORTRIPTYLINE; PARGYLINE; PHENIPRAZINE; PROTRIPTYLINE; SELEGILINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; DEPRESSION; INDUCED HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PSYCHOLOGICAL ASPECT; PTOSIS; RAT; STRUCTURE ACTIVITY RELATION;

ANIMAL; ANTIDEPRESSIVE AGENTS; DESIPRAMINE; GAMMA-AMINOBUTYRIC ACID; MALE; MICE; MONOAMINE OXIDASE INHIBITORS; NOREPINEPHRINE; RATS; RATS, INBRED STRAINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

EID: 0023892787     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00401a031     Document Type: Article

References (29)

1. Maxwell, R. A.; White, H. L. Handbook of Psychopharmacology; Iversen, L. L., Iversen, S. D., Snyder, S. H., Eds.; Plenum: New York, 1978; Vol. 14, pp 83.
2. Kaiser, C.; Setler, P. E. Burgers Medicinal Chemistry, Part III; Wolff, M. E., Ed.; Wiley: New York, 1981; pp 1061.
3. Blackwell, B. Drugs 1981, 21, 201.
4. Glassman, A. H.; Bigger, J. T. J. Arch. Gen. Psychiatry 1981, 38, 815.
5. Marshal, J. B.; Forker, A. D. Am. Heart J. 1982, 103, 401.
6. Blackwell, B. Lancet 1963, 2, 849.
7. Hollister, L. E. Ann. Intern. Med. 1978, 89, 78.
8. Hollister, L. E. Drugs 1981, 22, 129.
9. Antidepressants Neurochemical, Behavioral and Clinical Perspectives; Enna, S. J., Malick, J. B., Richelson, E., Eds.; Raven: New York, 1981.
10. Ohnmacht, C. J.; Malick, J. B.; Frazee, W. J. Annu. Rep. Med. Chem. 1983, 18, 41.
11. Maxwell, R. A. Drug Dev. Res. 1983, 3, 203.
12. Carr, A. A.; Huber, E. W.; Kane, J. M.; Miller, F. P. J. Org. Chem. 1986, 51, 1616.
13. Sandström, J.; Wennerbeck, I. Acta Chem. Scand. 1966, 20, 57.
14. Durant, G. J. J. Chem. Soc. C 1967, 92.
15. Kane, J. M. Synthesis 1987, 912.
16. Young, G.; Oates, W. J. J. Chem. Soc. 1901, 79, 659.
17. Hoggarth, E. J. Chem. Soc. 1949, 1160.
18. Mhasalkar, M. Y.; Shah, M. H.; Nikam, S. T.; Anantanarayanan, K. G.; Deliwala, C. V. J. Med. Chem. 1970, 13, 672.
19. Kubota, S.; Uda, M. Chem. Pharm. Bull. 1975, 23, 955.
20. Colpaert, F. C.; Lenaerts, F. M.; Niemegeers, C. J. E.; Janssen, P. A. J. Arch. Int. Pharmacodyn. 1975, 215, 40.
21. Kandel, A. Fed Proc. Fed. Am. Soc. Exp. Biol. 1966, 25, 385.
22. Niemegeers, C. J. E. Industrial Pharmacology; Fielding, S., Lai, H., Eds.; Futura: New York, 1975; Vol. 2, pp 73.
23. Kubota, S.; Uda, M. Chem. Pharm. Bull. 1973, 21, 1342.
24. Sulser, F.; Vetulani, J.; Mobley, P. L. Biochem. Pharmacol. 1978, 27, 257.
25. Schultz, J.; Siggins, G. R.; Schorer, F. W.; Turck, M.; Bloom, F. E. J. Pharmacol. Exp. Ther. 1981,216, 28.
26. Yeh, M. H.; Woodward, D. J. J. Pharmacol. Exp. Ther. 1983, 226, 126.
27. Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923.
28. Dudley, M. W.; Butcher, L. L.; Kammerer, R. C.; Cho, A. K. J. Pharmacol. Exp. Ther. 1981, 217, 834.
29. Sorensen, S. M.; Johnson, S. W.; Freedman, R. Brain Res. 1982, 247, 365.